Literature DB >> 30415158

Update on glucose in critical care.

Olivier Lheureux1, Danielle Prevedello1, Jean-Charles Preiser2.   

Abstract

The aim of this review is to summarize recent developments on the mechanisms involved in stress hyperglycemia associated with critical illness. Different aspects of the consequences of stress hyperglycemia as well as the therapeutic approaches tested so far are discussed: the physiological regulations of blood glucose, the mechanisms underlying stress hyperglycemia, the clinical associations, and the results of the prospective trials and meta-analyses to be taken into consideration when interpreting the available data. Current recommendations, challenges, and technological hopes for the future are be discussed.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Dysglycemia; Glucose monitoring; Hyperglycemia; Hypoglycemia; Insulin therapy; Metabolic stress; Stress hyperglycemia

Mesh:

Substances:

Year:  2018        PMID: 30415158     DOI: 10.1016/j.nut.2018.06.027

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  3 in total

1.  Glycemic control in critically ill patients with or without diabetes.

Authors:  Ka Man Fong; Shek Yin Au; George Wing Yiu Ng
Journal:  BMC Anesthesiol       Date:  2022-07-16       Impact factor: 2.376

Review 2.  Updates in Glycemic Management in the Hospital.

Authors:  Wasineenart Mongkolpun; Bruna Provenzano; Jean-Charles Preiser
Journal:  Curr Diab Rep       Date:  2019-11-20       Impact factor: 4.810

3.  Individualised versus conventional glucose control in critically-ill patients: the CONTROLING study-a randomized clinical trial.

Authors:  Julien Bohé; Hassane Abidi; Vincent Brunot; Amna Klich; Kada Klouche; Nicholas Sedillot; Xavier Tchenio; Jean-Pierre Quenot; Jean-Baptiste Roudaut; Nicolas Mottard; Fabrice Thiollière; Jean Dellamonica; Florent Wallet; Bertrand Souweine; Alexandre Lautrette; Jean-Charles Preiser; Jean-François Timsit; Charles-Hervé Vacheron; Ali Ait Hssain; Delphine Maucort-Boulch
Journal:  Intensive Care Med       Date:  2021-09-29       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.